The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Proglumide, gemcitabine (GEM), and nab-paclitaxel (NAB-P) in patients (pts) with pancreatic ductal adenocarcinoma (PDAC): Results of the phase 1 PROGEM trial.
 
Jill Smith
Patents, Royalties, Other Intellectual Property - Proglumide patent
 
Marcus Noel
Consulting or Advisory Role - Ipsen; Merus; Moderna Therapeutics; Pfizer
Speakers' Bureau - Celgene; Daiichi Sankyo/Astra Zeneca; Taiho Pharmaceutical
Research Funding - ERYTECH Pharma
 
Reetu Mukherji
Honoraria - NCODA
Consulting or Advisory Role - Aptitude Health; Medscape
Speakers' Bureau - Merck
Research Funding - Genentech (Inst); Natera (Inst)
Travel, Accommodations, Expenses - Arcus Biosciences; Rocky Mountain Oncology Society
 
John Marshall
Employment - Caris Life Sciences; Colorectal Cancer Alliance; Indivumed
Leadership - 2curex; Colorectal Cancer Alliance
Honoraria - Arcus Biosciences; Astellas Pharma; AstraZeneca/MedImmune; Bayer/Onyx; Merck; Pfizer; Seagan; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - AstraZeneca; Merck; Pfizer; Seagen; Taiho Pharmaceutical; Takeda
Speakers' Bureau - Merck; Pfizer; Seagan; Taiho Pharmaceutical
Research Funding - Genentech; Natera
 
Princess Jones
No Relationships to Disclose
 
Gakiza Christal Nkulikiyimana
No Relationships to Disclose
 
Hong Cao
No Relationships to Disclose
 
Wenqiang Chen
No Relationships to Disclose
 
Bhaskar Kallakury
No Relationships to Disclose
 
John Kwagyan
No Relationships to Disclose
 
Benjamin Weinberg
Employment - Apple (I)
Stock and Other Ownership Interests - Apple (I)
Honoraria - Caris Life Sciences; Primum
Consulting or Advisory Role - Agenus; CytoDyn; DoMore Diagnostics; Foundation Medicine; Merus NV; Regeneron
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Jazz Pharmaceuticals; Merus NV; Natera; Pfizer; Seagen; Sirtex Medical
Research Funding - BioXCel therapeutics (Inst); Immune System Key (Inst); Ipsen (Inst); Merck (Inst)
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Merus NV